Intellia Therapeutics Inc (FRA:38I)
€ 13.565 -0.175 (-1.27%) Market Cap: 1.44 Bil Enterprise Value: 903.64 Mil PE Ratio: 0 PB Ratio: 1.53 GF Score: 57/100

Q1 2019 Intellia Therapeutics Inc Earnings Call Transcript

May 02, 2019 / 12:00PM GMT
Release Date Price: €12.93 (-12.40%)
Operator

Good morning. My name is Jessica and I will be your conference operator today. Welcome to the Intellia Therapeutics First Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

At the time, I would like to turn it over to Lina Li, Senior Manager of Investor Relations at Intellia. Please proceed.

Lina Li

Thank you, operator. Good morning, and thank you all for joining us today to discuss Intellia's first quarter 2019 operational highlights and financial results. Earlier this morning, we issued a press release outlining our progress this quarter and the topics we plan to discuss on today's call. This release can be found in the Investors section of our website at www.intelliatx.com, and there is also a presentation available for download under the Events & Presentations section so that you can follow along.

This call is being broadcast live, and a replay will also be archived on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot